Pharming (PHAR) Intangibles (2019 - 2026)
Pharming (PHAR) reported Intangibles of $125.67 million for Q3 2026, down 6.9% from $134.93 million a year earlier and down 1.9% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Intangibles (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharming posted Intangibles of $135.54 million, up 122.1% from FY2024.
- Intangibles has a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- By year, Intangibles came in at $61.04 million in FY2024 (-14.4%), $71.27 million in FY2023 (-5.1%), $75.12 million in FY2022 (-10.4%) and $83.83 million in FY2021 (-10.9%).
- The Q3 2026 figure ranks as the lowest quarterly Intangibles since Q4 2024.
- Year over year, Intangibles has now declined in each of the last three quarters, with growth averaging 49.7% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q4 2025 (growth of 122.1%); the low point was Q3 2022 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $128.08 million (Q2 2026), $130.99 million (Q1 2026) and $135.54 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Pharming | 898.85 Mn | 429.52 Mn | - | 135.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 125.67 Mn |
| Jun 30, 2026 | 128.08 Mn |
| Mar 31, 2026 | 130.99 Mn |
| Dec 31, 2025 | 135.54 Mn |
| Sep 30, 2025 | 134.93 Mn |
| Jun 30, 2025 | 135.90 Mn |
| Mar 31, 2025 | 138.86 Mn |
| Dec 31, 2024 | 61.04 Mn |
| Sep 30, 2024 | 67.10 Mn |
| Jun 30, 2024 | 66.57 Mn |
| Mar 31, 2024 | 68.30 Mn |
| Dec 31, 2023 | 71.27 Mn |
| Sep 30, 2023 | 69.85 Mn |
| Jun 30, 2023 | 73.41 Mn |
| Mar 31, 2023 | 75.61 Mn |
| Dec 31, 2022 | 75.12 Mn |
| Sep 30, 2022 | 70,123.00 |
| Jun 30, 2022 | 75.77 Mn |
| Mar 31, 2022 | 81.32 Mn |
| Dec 31, 2021 | 83.83 Mn |
API Access
Pharming Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();